Articles published by Anebulo Pharmaceuticals, Inc.
![](https://mms.businesswire.com/media/20240722151136/en/1407796/22/ANEB_Logo_white.jpg)
![](https://mms.businesswire.com/media/20240515982468/en/1407796/22/ANEB_Logo_white.jpg)
![](https://mms.businesswire.com/media/20240213596703/en/1407796/22/ANEB_Logo_white.jpg)
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
February 13, 2024
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20231114101311/en/1407796/22/ANEB_Logo_white.jpg)
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
November 14, 2023
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20231006392162/en/1909469/5/Richie.jpg)
![](https://mms.businesswire.com/media/20231006308251/en/1909511/22/5363666cANEB_Logo_white.jpg)
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors
October 06, 2023
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20230920248131/en/1407796/22/ANEB_Logo_white.jpg)
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates
September 20, 2023
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20230830331645/en/1407796/22/ANEB_Logo_white.jpg)
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20230821471828/en/1407796/22/ANEB_Logo_white.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates
February 10, 2023
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20230109005343/en/1680150/22/ANEB_Logo_white.jpg)
![](https://mms.businesswire.com/media/20221110005403/en/1632447/4/ANEB_Logo_white.jpg)
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates
November 10, 2022
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20221101006250/en/1621512/4/ANEB_Logo_white.jpg)
Anebulo Pharmaceuticals Announces Appointment of Nat Calloway, Ph.D., to Board of Directors
November 01, 2022
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20220926005229/en/1407796/4/ANEB_Logo_white.jpg)
Anebulo Pharmaceuticals Announces $6.6 Million Private Placement Financing
September 26, 2022
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20220926005230/en/1407796/4/ANEB_Logo_white.jpg)
![](https://mms.businesswire.com/media/20220920005329/en/1576449/4/ANEB_Logo_white.jpg)
Anebulo Pharmaceuticals to Webcast R&D Day on September 26, 2022
September 20, 2022
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20220909005220/en/1566734/4/ANEB_Logo_white.jpg)
![](https://mms.businesswire.com/media/20220823005835/en/1551874/4/ANEB_Logo_white.jpg)
Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26
August 23, 2022
Via Business Wire
Tickers
ANEB
![](https://mms.businesswire.com/media/20220705005289/en/1504274/4/ANEB_Logo_white.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20220524005973/en/1465947/4/ANEB_Logo_white.jpg)
Via Business Wire
Tickers
ANEB
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20220401005131/en/1407800/4/4525308cANEB_Logo_white.jpg)
![](https://mms.businesswire.com/media/20220211005134/en/1356873/4/ANEB_Logo_white.jpg)
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2022 Financial Results and Recent Updates
February 11, 2022
Via Business Wire
Tickers
ANEB
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Anebulo Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference
January 06, 2022
Via Business Wire
Tickers
ANEB
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Anebulo Pharmaceuticals Appoints Scott L. Anderson as Head of Investor Relations and Public Relations
January 06, 2022
Via Business Wire
Tickers
ANEB
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director
January 04, 2022
Via Business Wire
Tickers
ANEB
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.